Pfizer CEO Signs Drug Companies' Open Letter Opposing Abortion Pill Decision
Pfizer's CEO signed an open letter Monday advocating for the reversal of a judge's decision to suspend FDA approval of the abortion pill, Reuters reported.
Stay updated with breaking news from Recode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer's CEO signed an open letter Monday advocating for the reversal of a judge's decision to suspend FDA approval of the abortion pill, Reuters reported.
Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.
Pfizer's CEO, along with 300 other pharmaceutical and biotech executives, signed a letter calling for the reversal of a ruling that suspended the sales of abortion pill mifepristone.
Last week’s ruling undermines the FDA’s authority, the letter’s authors wrote, adding that it ignores decades of scientific evidence and legal precedent
Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone, citing its impact on the FDA and the biotech industry.